Stay updated on Aflibercept vs Bevacizumab vs Ranibizumab for DME Clinical Trial
Sign up to get notified when there's something new on the Aflibercept vs Bevacizumab vs Ranibizumab for DME Clinical Trial page.

Latest updates to the Aflibercept vs Bevacizumab vs Ranibizumab for DME Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedNew notes clarify that publications are voluntarily provided by the study submitter and may be auto-filled from PubMed, with some items potentially not directly about the study. The revision tag has been updated to v3.3.2.SummaryDifference0.1%

- Check27 days agoChange DetectedThe page no longer displays the government funding status notice at the top of the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check49 days agoChange DetectedThe two screenshots show the same Study Details page (NCT01627249) with no noticeable changes to content or layout.SummaryDifference0.2%

- Check70 days agoChange DetectedAdded a prominent operating-status notice and a v3.2.0 version tag, replacing the prior v3.1.0 revision.SummaryDifference2%

- Check78 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0; no substantive changes to content or important data.SummaryDifference0.0%

- Check92 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2, and the Back to Top link has been removed.SummaryDifference0.1%

Stay in the know with updates to Aflibercept vs Bevacizumab vs Ranibizumab for DME Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Aflibercept vs Bevacizumab vs Ranibizumab for DME Clinical Trial page.